Skip to main content
. 2017 Mar 1;8:100. doi: 10.3389/fphar.2017.00100

FIGURE 2.

FIGURE 2

The changing pharma model (adapted from Personal Communication: Tufts Centre for the Study of Drug Development, 2012).